Status:
RECRUITING
Clinical Outcomes After Acute Pulmonary Embolism
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Pulmonary Embolism
Eligibility:
All Genders
Brief Summary
To investigate safety and effectiveness of PE treatment according to the decision of the multi-disciplinary pulmonary embolism response team (PERT) and to define and optimize treatment indications, in...
Detailed Description
This single-center cohort study is designed to retrospectively and prospectively collect treatment and outcome data related to patients with PE and after activation of the PERT. Treatment information ...
Eligibility Criteria
Inclusion
- Consecutive patients with pulmonary embolism matching the criteria for treatment according to the decision of the PERT.
- Written informed consent
Exclusion
- High probability of non-adherence to the follow up requirements
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT04355975
Start Date
May 1 2020
End Date
December 31 2030
Last Update
December 15 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Bern - Inselspital
Bern, Canton of Bern, Switzerland, 3010
2
University Hospital Bern
Bern, Switzerland, 3010